Incorporating genetic data to clinical information and therapies:
NGS / SNPChip: Comprehensive technological solutions for precise, personalized medicine & biology
GGenetracer Biotech has the authorization of the counseling of health as authorized Center of Genetics (U.78) to market its first two major lines of business, products based on genotyping (SNPchip) and sequencing (NGS).
Our goal is to both scientific development and the marketing of multiple products in the field of nutritional Genomics, pharmacogenetics, cancer, (lung cancer and colon, breast cancer or the full panel of cancer), hereditary diseases, the exome and transcriptome analysis.
These products can be self-developed based on a close collaboration with health workers through which it will be available or full (laboratories of clinical analyses, hospitals, offices, pharmacy, etc).
“I had an excellent experience working with Genetracer Biotech on Ampliseq Transcriptome Human Gene Panel with RNA samples from urine, formalin fixed paraffin embedded and laser capture microdissection.”
On November 6 2015, Genetracer Biotech has participated at the "II Conference of Young Scientists of Cantabria". Dr. Carlos Cortijo, CEO at Genetracer Biotech, has participated in a Roundtable entitled "Present and Future of Research [...]
Publication of the report on the Genetracer Biotech's activities that was published in the Annual Report of Innovation in Spain 2015, edited by INNOVASPAIN https://lnkd.in/ekR7aFu. GENETRACER BIOTECH_Anuario Inovación
Based on experience gained in the field of oncology, Genetracer Biotech has become EQA (External Quality Assessment) Assessor Scheme for lung cancer. The objective is annual provision of EQA schemes which meet [...]